PerspectiveCancer

Drug Resistance, Epigenetics, and Tumor Cell Heterogeneity

Science Translational Medicine  21 Apr 2010:
Vol. 2, Issue 28, pp. 28ps19
DOI: 10.1126/scitranslmed.3001056

You are currently viewing the abstract.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Abstract

The resistance of cancer cells to various therapeutic agents and modalities is a crucial issue in clinical oncology. A recent Cell paper highlights how changes at the chromatin level control drug sensitivity and provides insight into more effective strategies for treating cancer with combination therapies.

Footnotes

  • Citation: T. Hoey, Drug resistance, epigenetics, and tumor cell heterogeneity. Sci. Transl. Med. 2, 28ps19 (2010).

View Full Text